Bone marrow macrophage iron grade and survival of HIV-seropositive patients

AIDS

Volumn 13, Issue 3, 1999, Pages 375-380

  De Monyé, Cécile ^a,b,d   Karcher, Donald S ^a   Boelaert, Johan R ^c   Gordeuk, Victor R ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

^c General Hospital St Jan   (Belgium)

^d Kerkstraat 21bis   (Netherlands)

Author keywords

Bone marrow; Candida spp; HIV; Iron stores; Mycobacterium spp; Opportunistic infections; Pneumocystis carinii; Survival

Indexed keywords

IRON;

ADULT; ARTICLE; BONE MARROW; CANDIDIASIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRON STORAGE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL; SURVIVAL TIME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BONE MARROW CELLS; COHORT STUDIES; FEMALE; HIV SEROPOSITIVITY; HUMANS; IRON; MACROPHAGES; MALE; RETROSPECTIVE STUDIES;

EID: 0033009848     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199902250-00010     Document Type: Article

References (47)

1. 1. Weinberg ED: Iron and infection. Microbiol Rev 1978 42:45-66.
2. Van Asbeck BS, Verbrugh HA, Van Oost BA, Marx JJM, Imhof HW, Verhoef J: Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload. BMJ 1982, 284:342-544.
3. Bullen JJ, Spalding PB, Ward CG, Gutteridge JMC Hemochromatosis, iron, and septicemia caused by Vibrio vulnificus. Arch Intern Med 1991, 751:1606-1609.
4. Boelaert JR, van Landuyt HW, Valcke YJ, et al.: The role of iron overload in Yersinia enterocolitica and Yersinia pseudotuberculosis bacteremia in hemodialysis patients. J Infect Dis 1987, 156:384-387.
5. Al-Khafaji B, Kralovic S, Smith RD: Increased hepatic iron in the acquired immunodeficiency syndrome: an autopsy study Modern Pathol 1997, 10:474-480.
6. Gordeuk VR, McLaren CE, MacPhail AP, Deichsel C, Bothwell TH: Associations of iron overload in Africa with hepatocellular carcinoma and tuberculosis: Strachan's 1929 thesis revisited. Blood 1996, 87:3470-3476.
7. De Sousa M: Immune cell functions in iron overload. Clin Exp Immunol 1989, 75:1-6.
8. Weiss G, Wachter H, Fuchs D: Linkage of cell-mediated immunity to iron metabolism. Immunol Today 1995, 16:495-500.
9. Weiss G, Fuchs D, Hausen A, Reibnegger C, Werner ER, Werner-Felmayer G, Wachter H: Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1. Exp Haematol 1992, 20:605-610.
10. Cantinieaux B, Hariga C, Ferster A, De Maertelaere E, Toppet M, Fondu P: Neutrophil dysfunctions in thalassaemia major: the role of cell iron overload. Eur J Haematol 1987, 39:28-34.
11. Cantinieaux B, Boelaert JR, De Meuleneire J, Kerrels V, Fondu P: Neutrophils from patients with secondary haemosiderosis contain excessive amounts of autotoxic iron. Eur J Haematol 1993, 51:161-165.
12. Sattenlau QJ: HIV infection and the immune system. Biochem Biophys Acta 1989, 989:255-268.
13. Karcher DS, Frost AR: The bone marrow in human immunodeficiency (HIV)-related disease. Am J Clin Pathol 1991, 95:63-71.
14. Castella A, Croxson TS, Mildvan D, Witl DH, Zalusky R: The bone marrow in AIDS: a histologic, hematologic, and microbiologic study. Am J Clin Pathol 1985, 84:425-432.
15. Treacy M, Lai L, Costello C, Clark A: Peripheral blood and bone marrow abnormalities in patients with HIV related disease. Br J Haematol 1987, 65:289-294.
16. Shenoy CM, Lin JH. Bone marrow findings in acquired immunodeficiency syndrome (AIDS). Am J Med Sci 1986, 292:372-375.
17. Goldin RD, Wilkins M, Dourakis S, Parkin J, Lindley R: Iron overload in multiply transfused patients who are HIV seropositive. J Clin Pathol 1993, 46:1036-1038.
18. Boelaert JR, Weinberg GA, Weinberg ED: Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management. Infect Agents Dis 1996, 5:36-46.
19. Roux-Lombard P, Modoux C, Cruchaud A, Dayer J: Purified blood monocytes from HIV-1 infected patients produce high levels of TNT-α and IL-1. Clin Immunol Immunopathol 1989, 50:374-384.
20. Alvarez-Hernandez X, Liceaga J, McKay IC, Brock JH: Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest 1989, 61:319-322.
21. Pollack S, Weaver J: Azidothymidine (AZT)-induced siderosis. Am J Hematol 1993, 43:230-233.
22. Gordeuk VR, McLaren GD, Samowitz W: Etiologies, consequences, and treatment of iron overload. Crit Rev Clin Lab Sci 1994, 31:89-133.
23. Gordeuk VR: Hereditary and nutritional iron overload. Balliere's Clin Haematol 1992, 5:169-186.
24. Martin JB, Easley-Shaw T, Collins C: Use of selected vitamin and mineral supplements among individuals infected with HIV. J Am Diet Assoc 1991, 91:476-478.
25. Abrams B, Duncan D, Hertz-Piccioti I: A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men. J Acquired Immune Defic Syndr 1993, 6:949-958.
26. Costagliola DG, de Montalembert M, Lefrère JJ, et al.: Dose of desferrioxamine and evolution of HIV-1 infection in thalassaemic patients. Br J Haematol 1994, 87:849-852.
27. Salhi Y, Costagliola D, Rebulla P, et al.: Serum ferritin, desferrioxamine, and evolution of HIV-1 infection in thalassemic patients. J Acquired Immune Defic Syndr 1998, 18:473-478.
28. Salmon-Céron D, Fontbonne A, Saba J, et al.: Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. J Infect Dis 1995, 172:656-664.
29. Jacobus DP: Randomization to iron supplementation of patients with advanced HIV disease and inadvertent but controlled study with results important for patient care. J Infect Dis 1996, 172:1044-1045.
30. Gale E, Torrance J, Bothwell T: The quantitative estimation of total iron stores in human bone marrow. J Clin Invest 1963, 42:1076-1082.
31. Winer BJ: Statiscal Principles in Experimental Design, 2nd edn. New York: McGraw Hill; 1971.
32. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
33. Mantell M. Evaluation of survival data and two rank order statistics arising in its consideration. Cancer Chemother Rep 1966, 50:163-170.
34. Cox DR: Regression models and life-tables. J R Stat Soc (B) 1972, 34:187-202.
35. World Health Organization: Interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidemiol Rec 1990, 65:221-224.
36. Vamvakas E, Kaplan HS: Early transfusion and length of survival in acquired immune deficiency syndrome: experience with a population receiving medical care at a public hospital. Transfusion 1993, 33:111-118.
37. Sloand E, Kumar P, Klein HG, Merritt S, Sacher R: Transfusion of blood components to persons infected with HIV type 1: relationship to opportunistic infection. Transfusion 1994, 34:48-53.
38. Wenger JD, Whalen CC, Lederman MM, et al.: Prognostic factors in acquired immunodeficiency syndrome. J Gen Intern Med 1988, 3:464-470.
39. + T-lymphocyte measures in the treatment of individuals infected with human immunodeficiency virus type 1. Arch Intern Med 1994, 154:1561-1573.
40. Mencacci A, Cenci E, Boelaert JR, et al.: Iron overload alters T helper cell responses to Candida albicans in mice. J Infect Dis 1997, 175:1467-1476.
41. Kochan I: The role of iron in bacterial infections, with special consideration of host-tubercle bacillus interaction. Curr Top Microbiol Immunol 1973, 60:1-30.
42. Dhople AM, Ibanez MA, Poirier TC: Role of iron in the pathogenesis of Mycobacterium avium infection in mice. Microbios 1996, 87:77-87.
43. Caroline L, Rosner F, Kosinn PJ: Elevated serum iron, low unbound transferrin and candidiasis in acute leukemia. Blood 1969, 34:441-451.
44. Murray MJ, Murray AB, Murray MB, Murray CJ: The adverse effect of iron repletion on the course of certain infections. BMJ 1978, 2:1113-1115.
45. Weinberg GA: Iron chelators as therapeutic agents against Pneumocystis carinii. Antimicrob Agents Chemother 1994, 38:997-1003.
46. Gomes S, Appelberg R: Evidence for a link between iron metabolism and Nramp1 gene function in innate resistance against Mycobacterium avium. Immunology 1998, 95:165-168.
47. Delanghe JR, Langlois MR, Boelaert JR, et al.: Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. AIDS 1998, 12:1027-1032.